- We will send in 10–14 business days.
/images/books/3470397/9780444639394.jpg)
- Publisher: Elsevier
- ISBN-10: 044463939X
- ISBN-13: 9780444639394
- Format: 15.2 x 22.9 x 1.3 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Progress in Medicinal Chemistry (e-book) (used book) | bookbook.eu
Reviews
Description
Progress in Medicinal Chemistry, Volume 56 provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a potential new era for Chagas Disease drug discovery, and imaging in drug development. Specific chapters cover timely topics, such as the development of LRRK2 inhibitors for the treatment of Parkinson's, and recent discoveries and developments in TRPA1 modulators.
Users will find a comprehensive resource on the topic of medicinal chemistry that also discusses avenues for the acceleration of drug discovery programs.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 18d.17:42:39
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Elsevier
- ISBN-10: 044463939X
- ISBN-13: 9780444639394
- Format: 15.2 x 22.9 x 1.3 cm, hardcover
- Language: English English
Progress in Medicinal Chemistry, Volume 56 provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a potential new era for Chagas Disease drug discovery, and imaging in drug development. Specific chapters cover timely topics, such as the development of LRRK2 inhibitors for the treatment of Parkinson's, and recent discoveries and developments in TRPA1 modulators.
Users will find a comprehensive resource on the topic of medicinal chemistry that also discusses avenues for the acceleration of drug discovery programs.
Reviews